Navigating the Regulatory Gauntlet: Critical Updates for Telehealth, Medspas, and Clinical Practices
Back to Blog
Regulatory RoundupApril 17, 2026

Navigating the Regulatory Gauntlet: Critical Updates for Telehealth, Medspas, and Clinical Practices

The healthcare regulatory landscape is in constant flux, with new enforcement actions and guidance shaping how telehealth, medspas, and clinical practices operate. This roundup cuts through the noise, providing a critical analysis of recent developments and their direct implications for your business.

9 min read10 views

The healthcare sector, particularly its rapidly evolving telehealth and aesthetic segments, is under unprecedented regulatory scrutiny. As TrueEval's editorial director, I've observed a clear trend: regulatory bodies are moving swiftly to close perceived loopholes, clarify ambiguities, and crack down on non-compliant practices. This isn't just about avoiding penalties; it's about building a resilient, compliant enterprise that can thrive amidst increasing oversight.

For more on this topic, see our analysis: Navigating the Regulatory Gauntlet: DOJ Scrutiny, CPOM Tightening, and Telehealth's Evolving Compliance Imperatives.

The Intensifying Scrutiny on Telehealth Fraud and Kickbacks

The Department of Justice (DOJ) has signaled, unequivocally, that its aggressive pursuit of telehealth fraud and kickback schemes is not abating. This isn't theoretical; it's a strategic priority with tangible consequences. The DOJ's focus extends beyond direct billing fraud to intricate arrangements that disguise illegal kickbacks, often involving marketing services, lead generation, or administrative fees. These actions highlight the federal government's commitment to safeguarding federal healthcare programs and ensuring legitimate patient care in the rapidly expanding telehealth sector.

For more on this topic, see our analysis: The Shifting Sands of Healthcare Compliance: Navigating Telehealth Fraud, CPOM, and State-Specific Scrutiny.

For telehealth brands, the risk areas are broad: billing for services not rendered, medically unnecessary services, or services provided by unqualified personnel. The DOJ is particularly vigilant about arrangements that incentivize referrals through illegal kickbacks, often disguised as marketing fees, administrative services, or consulting agreements. Any financial relationship with lead generators, laboratories, pharmacies, or other service providers must be meticulously structured to comply with the Anti-Kickback Statute (AKS) and its safe harbors. Failure to do so can result in criminal charges, civil penalties under the False Claims Act (FCA), and exclusion from federal healthcare programs.

Medspas, dental practices, and chiropractic offices that integrate telehealth components or engage in referral relationships are also under the microscope. For instance, a medspa offering weight-loss or hormone-therapy services via telehealth must ensure that all prescriptions are medically necessary, based on a legitimate patient-provider relationship, and not influenced by illegal inducements. Similarly, dental and chiropractic practices referring patients for durable medical equipment (DME), diagnostic tests, or specialty consultations must ensure these referrals are based solely on clinical need, not on financial incentives. The DOJ's enforcement actions often target schemes where providers are paid for ordering unnecessary items or services, even if they claim to be acting on behalf of a telehealth company.

Actionable Insight: Robust compliance programs are no longer optional; they are a necessity. Implement strong internal controls, conduct regular audits, and provide ongoing training to staff on fraud, waste, and abuse prevention. This includes careful vetting of third-party vendors and ensuring that compensation arrangements are fair market value, commercially reasonable, and do not directly or indirectly induce referrals.

Corporate Practice of Medicine (CPOM): A Persistent Hurdle

The Corporate Practice of Medicine (CPOM) doctrine remains a formidable challenge, particularly for telehealth and medspa models seeking national scale. While some states offer more flexibility, others, like New York, maintain some of the nation's strictest prohibitions. This doctrine generally prevents corporations from employing physicians or controlling medical practice, aiming to protect physician autonomy and patient care from commercial influence.

New York's Strict CPOM: New York's approach is particularly unyielding. For telehealth companies, medspas, and other practices operating in the Empire State, a Physician-Controlled Management Services Organization (PC-MSO) structure is not merely advisable but essential. The core principle is that the professional entity (PE), owned and controlled by licensed New York physicians, must retain complete clinical autonomy and control over all medical decision-making, patient care, and professional employment. The MSO's role is strictly limited to providing non-clinical administrative, technical, and management services. Any perceived influence or control by the MSO over clinical aspects can trigger CPOM violations, leading to investigations by the New York State Education Department (NYSED) Office of Professional Discipline (OPD) or the Office of the Attorney General.

Nevada's Nuanced Approach: In contrast, Nevada presents a more flexible, yet still regulated, CPOM environment. While generally prohibiting corporate practice, Nevada's enforcement often allows for well-structured MSO models, especially for telehealth and medspa businesses. The critical compliance point here is ensuring that the MSO does not exert control over clinical decision-making, physician employment, or fee-splitting arrangements that could be construed as illegal. Practices must ensure their MSO agreements are meticulously drafted to delineate clear boundaries between administrative support and clinical autonomy.

DTC Telehealth Weight Loss Brands: For direct-to-consumer (DTC) telehealth weight loss brands, CPOM regulations are a critical compliance challenge. The tension between the corporate structure of a DTC platform and the requirement for physician autonomy means that simply contracting with physicians may not be enough. The nature of that contract, the degree of corporate influence on treatment protocols, and how fees are structured are all under scrutiny. For example, if a platform dictates specific weight loss treatments or formularies without independent physician judgment, it could be seen as exercising undue corporate control. Similarly, revenue-sharing models tied directly to the volume or type of prescriptions could be construed as illegal fee-splitting or inducements in states like California, Texas, Ohio, Delaware, Illinois, Michigan, New Jersey, Pennsylvania, and South Carolina.

Actionable Insight: For multi-state operators, a state-by-state CPOM analysis is non-negotiable. Engage legal counsel specializing in healthcare regulatory compliance to audit your business model, physician contracts, and marketing practices. Ensure that MSO agreements clearly delineate responsibilities, fee structures are fair market value, and the professional entity maintains ultimate clinical authority.

State-Specific Telehealth Regulations: A Patchwork of Requirements

The post-PHE era has solidified a complex patchwork of state-specific telehealth regulations, demanding meticulous attention from all virtual care providers. There is no single federal standard for many critical aspects of telehealth, particularly concerning the establishment of a valid patient-provider relationship, controlled substance prescribing, and informed consent.

Sexual Wellness Platforms and Controlled Substances: Telehealth platforms specializing in sexual wellness face unique challenges. The DEA's Ryan Haight Act generally requires an in-person medical evaluation before prescribing controlled substances via telemedicine, with exceptions. While the DEA has proposed new rules post-PHE, the landscape remains dynamic. State medical boards often have their own interpretations and additional restrictions, including limits on Schedule II substances and prohibitions on prescribing controlled substances for certain conditions via telehealth without prior in-person visits. This directly impacts how a sexual wellness platform can operate across all 50 states and D.C.

Chiropractic Telehealth: State chiropractic boards are increasingly defining the scope of telehealth for chiropractors. Many states require an in-person initial visit to establish a legitimate patient-practitioner relationship, limiting fully remote care. This means telehealth brands offering chiropractic services must carefully vet patients or consider hybrid models. For chiropractic offices, telehealth can enhance follow-ups but generally cannot replace hands-on diagnostic or therapeutic procedures. This impacts practices in states like Texas, Florida, and California, among others.

Informed Consent: The application of informed consent to telehealth introduces specific considerations that vary significantly by state. Simply having a general consent form is insufficient. Practices must tailor their consent processes to meet the explicit mandates of each jurisdiction where they operate and where their patients reside. Some states require explicit disclosure of the potential for technology failures, while others may mandate specific language regarding patient data privacy in a telehealth context. This applies to all 50 states and D.C.

District of Columbia Pharmacy Board Regulations: The DC Board of Pharmacy sets specific regulations governing telehealth prescribing, compounding, and medication fulfillment. Providers must ensure their initial patient assessments meet the standards for prescribing, particularly for controlled substances. Medspas and other aesthetic practices utilizing telehealth for consultations or prescribing must align with DC's requirements, including maintaining comprehensive patient records and verifying prescription legitimacy. Any medication fulfillment must occur with DC-licensed entities.

Actionable Insight: Implement dynamic consent workflows that can present state-specific disclosures. Conduct a comprehensive audit of your current consent practices against the requirements of every state you serve. For controlled substances, assume the most stringent state and federal requirements apply and build your protocols accordingly. Invest in compliance technology that can manage and track state-specific requirements.

Supervision and Delegation: A Focus on Patient Safety

Regulatory bodies are clarifying and strengthening requirements for the supervision and delegation of duties to physician assistants (PAs) and advanced registered nurse practitioners (ARNPs), particularly in telehealth and medspa settings. This reflects a growing emphasis on patient safety and accountability in evolving care models.

Washington State Medical Commission (WMC) and Nursing Care Quality Assurance Commission (NCQAC): These commissions establish specific requirements for physician and ARNP supervision and delegation, highly relevant for telehealth and medspa services in Washington State. The regulations demand a robust, documented process for ongoing collaboration, review of patient charts, and availability for consultation. For medspas, the WMC and NCQAC rules dictate that delegating physicians or collaborating ARNPs must ensure the PA or ARNP has the necessary training and competency for each procedure, including a thorough understanding of potential complications and emergency protocols. This extends to continuous professional development and regular performance reviews, especially for procedures involving injectables, lasers, or other advanced modalities.

Actionable Insight: Merely having a supervising physician or collaborating ARNP on paper is insufficient. Implement systems to facilitate effective collaboration, including secure communication channels and clear protocols for escalation and review. Maintain meticulous records of delegation agreements, training, and ongoing supervision to demonstrate compliance. Conduct regular audits of supervision practices and provide staff training on regulatory requirements.

Billing and Coding: The Foundation of Financial Compliance

Accurate billing and coding are not just administrative tasks; they are critical risk management functions. Missteps can lead to claim denials, recoupments, audits, and severe penalties, including False Claims Act violations.

Commercial Insurance: Providers must stay updated on each payer's specific telehealth policies, which vary widely by plan and state. This includes understanding covered services, acceptable modalities (audio-only vs. audio-visual), eligible providers, and any state-specific parity laws. Accurate use of CPT/HCPCS codes, telehealth modifiers (e.g., -95, -GT, -GQ, -G0), and place of service (POS) codes (e.g., 02 for telehealth provided from a location other than the patient's home, 10 for telehealth provided in the patient's home) is paramount. Failure to apply these correctly will result in claim rejections and potential audit triggers.

Self-Pay Models: While seemingly simpler, self-pay models introduce their own set of compliance challenges, primarily around price transparency and consumer protection. The No Surprises Act mandates good faith estimates for uninsured and self-pay patients. Telehealth businesses must provide clear, upfront pricing for all services, including any potential ancillary fees. Avoiding deceptive marketing practices and ensuring that services are delivered as advertised is crucial to prevent consumer complaints and regulatory scrutiny from state attorneys general or consumer protection agencies.

Actionable Insight: Implement robust internal controls, staff training, and regular audits. Develop clear policies and procedures for telehealth documentation, billing, and patient financial counseling. For practices operating across state lines, invest in compliance expertise and technology that can adapt to evolving payer rules and regulatory mandates.

What This Means For Your Practice

The regulatory environment for healthcare businesses is characterized by increasing complexity and heightened enforcement. For telehealth operators, medspas, and clinical practices, this means a proactive, rather than reactive, approach to compliance is no longer optional—it is fundamental to sustainable growth and risk mitigation. The days of operating under broad interpretations or hoping to fly under the radar are over.

Key Takeaways:

  • State-Specific Nuance is Paramount: There is no one-size-fits-all compliance strategy. Every state, and often every professional board within a state, has unique requirements for telehealth, CPOM, supervision, and prescribing. A granular, state-by-state analysis is essential.
  • Documentation is Your Defense: Meticulous record-keeping for patient encounters, informed consent, supervision agreements, and billing practices provides the evidentiary basis for your compliance efforts.
  • Structure Matters: For CPOM-sensitive states, carefully constructed MSO or PC-MSO models are critical. Ensure genuine clinical autonomy for licensed professionals and avoid arrangements that could be construed as illegal fee-splitting or corporate control over medical decisions.
  • Stay Ahead of Enforcement: The DOJ's focus on telehealth fraud and kickbacks underscores the need for robust anti-fraud programs and careful vetting of all third-party relationships.
  • Invest in Expertise: Navigating this landscape requires specialized legal and compliance expertise. Regular audits, staff training, and ongoing monitoring of regulatory changes are non-negotiable.

By embracing these principles, your practice can not only avoid costly penalties but also build a reputation for ethical, high-quality care that distinguishes you in a competitive and heavily regulated market. TrueEval remains committed to providing the insights and infrastructure necessary to navigate this complex terrain successfully.


Further Reading

telehealth complianceCPOMmedspa regulationsDOJ enforcementstate medical boardsbilling and coding

Enjoyed this article?

Get our bi-weekly compliance digest delivered straight to your inbox. Join healthcare leaders staying ahead of regulatory changes.